Literature DB >> 21763992

Treatment of hyperpigmentation.

Anthony M Rossi1, Maritza I Perez.   

Abstract

Disorders of hyperpigmentation encompass a plethora of pigmentary problems that can range from inherited to acquired. This article focuses on two prevalent disorders of hyperpigmentation and their treatment: melasma and postinflammatory hyperpigmentation. Each represents an acquired disorder of dyspigmentation with multifactorial etiology, which preferentially affects darker phototypes. Treatment can require a combination of medical, surgical, and laser modalities, as well as patience by both physician and patient. Treatment is limited mainly by the skin phototype of the patient, as darker skin types are more susceptible to adverse effects of treatment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763992     DOI: 10.1016/j.fsc.2011.05.010

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  3 in total

1.  Human nonvisual opsin 3 regulates pigmentation of epidermal melanocytes through functional interaction with melanocortin 1 receptor.

Authors:  Rana N Ozdeslik; Lauren E Olinski; Melissa M Trieu; Daniel D Oprian; Elena Oancea
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

2.  Design, synthesis and evaluation of cinnamic acid ester derivatives as mushroom tyrosinase inhibitors.

Authors:  Zhaojun Sheng; Siyuan Ge; Ximing Xu; Yan Zhang; Panpan Wu; Kun Zhang; Xuetao Xu; Chen Li; Denggao Zhao; Xiaowen Tang
Journal:  Medchemcomm       Date:  2018-04-25       Impact factor: 3.597

3.  Postinflammatory hyperpigmentation after human cold pain testing.

Authors:  Melissa J Wolz; Katelyn E Sadler; Caela C Long; Daniel S Brenner; Brian S Kim; Robert W Gereau; Benedict J Kolber
Journal:  Pain Rep       Date:  2016-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.